Total Payments
$991.27
2024 Payments
$313.09
Companies
6
Transactions
37
Medicare Patients
2,360
Medicare Billing
$1.0M
Payment Breakdown by Category
Food & Beverage$777.12 (78.4%)
Education$214.15 (21.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $777.12 | 32 | 78.4% |
| Education | $214.15 | 5 | 21.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AKEBIA THERAPEUTICS INC | $389.54 | 19 | $0 (2024) |
| BAXTER HEALTHCARE | $200.96 | 6 | $0 (2019) |
| Ardelyx, Inc. | $162.18 | 7 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $156.71 | 2 | $0 (2020) |
| Amgen Inc. | $62.93 | 2 | $0 (2021) |
| Fresenius USA Marketing, Inc. | $18.95 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $313.09 | 14 | Ardelyx, Inc. ($162.18) |
| 2023 | $22.37 | 1 | AKEBIA THERAPEUTICS INC ($22.37) |
| 2022 | $77.53 | 4 | AKEBIA THERAPEUTICS INC ($77.53) |
| 2021 | $142.58 | 6 | AKEBIA THERAPEUTICS INC ($79.65) |
| 2020 | $151.05 | 4 | Otsuka America Pharmaceutical, Inc. ($95.51) |
| 2019 | $153.69 | 4 | BAXTER HEALTHCARE ($70.00) |
| 2018 | $130.96 | 4 | BAXTER HEALTHCARE ($130.96) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Education | In-kind items and services | $24.61 | General |
| Category: Nephrology | ||||||
| 11/21/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Nephrology | ||||||
| 11/21/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Education | In-kind items and services | $8.22 | General |
| Category: Nephrology | ||||||
| 10/17/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $29.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/17/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $1.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/29/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Phosphate binder for ESRD | ||||||
| 07/18/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: Nephrology | ||||||
| 07/18/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Education | In-kind items and services | $24.61 | General |
| Category: Nephrology | ||||||
| 06/20/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $32.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/20/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: Nephrology | ||||||
| 05/30/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $33.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/18/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $27.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/18/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $6.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/25/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $32.08 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/26/2023 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: Nephrology | ||||||
| 12/15/2022 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Nephrology | ||||||
| 10/20/2022 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Nephrology | ||||||
| 06/16/2022 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Nephrology | ||||||
| 02/28/2022 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Nephrology | ||||||
| 10/21/2021 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Nephrology | ||||||
| 09/16/2021 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $32.37 | General |
| Category: Nephrology | ||||||
| 05/24/2021 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Nephrology | ||||||
| 03/18/2021 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $30.56 | General |
| Category: Nephrology | ||||||
| 03/17/2021 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Nephrology | ||||||
| 01/21/2021 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Nephrology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 441 | 2,181 | $338,060 | $253,642 |
| 2022 | 11 | 553 | 2,074 | $277,844 | $204,807 |
| 2021 | 12 | 844 | 2,827 | $389,095 | $294,538 |
| 2020 | 10 | 522 | 2,100 | $363,815 | $249,217 |
Total Patients
2,360
Total Services
9,182
Medicare Billing
$1.0M
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 39 | 280 | $103,600 | $81,222 | 78.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 68 | 618 | $55,620 | $40,967 | 73.7% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 21 | 168 | $50,400 | $39,498 | 78.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 114 | 357 | $33,915 | $26,481 | 78.1% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 47 | 416 | $37,440 | $24,835 | 66.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 30 | 87 | $26,970 | $21,144 | 78.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 68 | 122 | $19,520 | $13,278 | 68.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $7,200 | $5,006 | 69.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 97 | $3,395 | $1,210 | 35.6% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 33 | 194 | $71,780 | $56,749 | 79.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 93 | 631 | $56,790 | $37,944 | 66.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 127 | 465 | $44,175 | $34,386 | 77.8% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 58 | 300 | $27,009 | $18,465 | 68.4% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 25 | 70 | $21,700 | $17,154 | 79.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 89 | 131 | $20,960 | $14,818 | 70.7% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 11 | 60 | $18,000 | $14,275 | 79.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 53 | 53 | $10,600 | $7,623 | 71.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 32 | 138 | $4,830 | $1,766 | 36.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 16 | 16 | $1,280 | $1,097 | 85.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 16 | 16 | $720.00 | $529.44 | 73.5% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 43 | 289 | $106,930 | $85,544 | 80.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 230 | 836 | $79,420 | $63,379 | 79.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 97 | 599 | $53,910 | $36,821 | 68.3% |
| 90966 | Home dialysis services per month, patient 20 years of age or older | Office | 2021 | 17 | 113 | $33,900 | $27,120 | 80.0% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 39 | 92 | $28,520 | $22,816 | 80.0% |
About Dr. Deno Kang, MD
Dr. Deno Kang, MD is a Internal Medicine healthcare provider based in Artesia, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1265428916.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deno Kang, MD has received a total of $991.27 in payments from pharmaceutical and medical device companies, with $313.09 received in 2024. These payments were reported across 37 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($777.12).
As a Medicare-enrolled provider, Kang has provided services to 2,360 Medicare beneficiaries, totaling 9,182 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology
- Location Artesia, CA
- Active Since 09/27/2005
- Last Updated 09/11/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1265428916
Products in Payments
- Auryxia (Drug) $254.07
- IBSRELA (Drug) $162.18
- Renal - Non Product Related (Biological) $130.96
- JYNARQUE (Drug) $95.51
- AURYXIA (Drug) $78.03
- Renal - PD (Device) $70.00
- Parsabiv (Drug) $62.93
- SAMSCA (Drug) $61.20
- Vafseo (Drug) $57.44
- Velphoro (Drug) $18.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Artesia
Dr. Rajiv Dhamija, M.d, M.D
Internal Medicine — Payments: $2,012
Internal Medicine $2,012
Yordan Orive Gomez, Md, MD
Internal Medicine — Payments: $775.35
Internal Medicine $775.35
Dr. Tzong-Yueh Hwang, M.d, M.D
Internal Medicine — Payments: $325.45
Internal Medicine $325.45
Dr. Manmohan Chawla, M.d, M.D
Internal Medicine — Payments: $229.87
Internal Medicine $229.87
Susan Trompeter, M.d, M.D
Internal Medicine
Internal Medicine